Background: Melanotic schwannoma is a rare tumor with indeterminate biologic behavior and varying treatment recommendations. Methods: We report 2 cases of pigmented melanotic schwannoma of the head and neck and perform literature review. The pathologic and immunohistochemical characteristics of melanotic schwannoma are reviewed. Results: Two cases of melanotic schwannoma are presented. Both cases underwent surgical resection with one patient receiving adjuvant radiation therapy. Conclusions: Melanotic schwannoma is a rare nerve sheath tumor that is frequently mistaken for malignant melanoma. We describe 2 cases of pigmented melanotic schwannoma of the head and neck with different presentations and review the histopathological and immunohistochemical features.
Introduction
Melanotic schwannoma is a rare neoplasm of neural crest origin composed of Schwann cells that contain melanosomes in varying stages of maturation. 1 The most common location of melanotic schwannomas is spinal and cranial nerve roots, 2 though they have been described in the cervical sympathetic chain. [3] [4] [5] [6] Although previously reported cases have been described as behaving in a clinically benign fashion, recent studies have advocated for reconsideration of the tumor as a malignancy due to propensity for local recurrence and metastasis. 2, 3, 7 There are no standard guidelines for the treatment of melanotic schwannoma; complete surgical excision is typically undertaken, but the efficacy of adjuvant therapy such as chemotherapy, radiotherapy, or immunotherapy is not well defined. Additionally, the factors that determine clinical course remain uncertain. In this study, we report 2 patients with melanotic schwannoma presenting as lateral neck masses.
Case Report

Case 1
A previously healthy 34-year-old Caucasian male presented with 1-year history of a lateral neck mass that rapidly grew over 2 months. The patient reported mild discomfort when sleeping, but denied any dysphagia and hoarseness. He denied any systemic symptoms such as weight loss, fever, night sweats, and syncopal episodes. Physical examination revealed a firm, 4-cm left neck mass with side-to-side mobility, but limited vertical mobility. No palpable cervical lymphadenopathy was present and all cranial nerves were intact.
Computed tomography (CT) scan of the neck revealed a 3.2 Â 2.9 Â 4.0 cm mass centered at the level of the hyoid bone, medial to the sternocleidomastoid muscle, pushing the internal and external carotid arteries anteromedially, with anterior displacement and compression of the internal jugular vein. Magnetic resonance imaging (MRI) showed a T1 and T2 hyperintense lesion with flow voids and no associated cervical lymphadenopathy ( Figure 1 ) consistent with a schwannoma.
Given the patient's age and rapid growth of the mass, the patient underwent surgical resection. Intraoperative relationships of the neoplasm were closely examined, and it was found to be emanating from the cervical sympathetic chain, and indistinguishable from it. Based on the preoperative imaging and intraoperative findings of a tumor associated with the sympathetic chain, an enucleation of the mass with preservation of capsule and nerve was completed. Gross examination of the mass revealed a dark, blue-tinged, well-encapsulated mass. Due to the abnormal color for a typical schwannoma, frozen section analysis was performed which revealed a pigmented neoplasm with marked cytologic atypia, concerning for malignant melanoma. Based on this possibility, a complete resection of the capsule and nerve was undertaken to ensure clearance of disease.
Microscopic examination revealed a heavily pigmented neoplasm, characterized by markedly pleomorphic cells, with bizarre nuclei. Immunohistochemistry (IHC) stains were positive for melanoma markers HMB-45, S100, and weakly positive for Melan-A again raising the possibility of a malignant melanoma. However, very low mitotic activity with essentially no atypical mitoses, lack of tumor necrosis and, crucially, the presence of scattered psammomatous calcifications, not typically seen in melanoma, corroborated with a negative history of a pigmented skin lesion, prompted consideration of other diagnoses. A reticulin stain was subsequently performed which showed a pericellular network pattern (Figure 2 ). Given these findings, a diagnosis of pigmented melanotic schwannoma was made.
Postoperatively, the patient had an expected Horner syndrome with ptosis and miosis of the left eye. He was discussed at multidisciplinary head and neck tumor board, and the decision was made for close observation. He did not receive any adjuvant therapy. At 1-year follow-up, the patient is disease free with no signs of persistent or recurrent disease on physical examination or MRI. He has persistent mild ptosis and miosis of the left eye.
Case 2
A previously healthy 29-year-old African American male presented with 6 months of left-sided otalgia, increased snoring, and worsening odynophagia. He presented to an outside emergency department with acute exacerbations of these symptoms. He was misdiagnosed with a peritonsillar abscess and transoral incision and drainage was attempted. The patient's symptoms persisted and imaging was obtained which showed a left parapharyngeal space mass. He was subsequently referred to our practice.
On physical examination, his left oropharynx revealed marked submucosal fullness and displacement of the palate with a fibrinous healing site on the surface consistent with recent incision and drainage. Externally, there was fullness appreciated in the left deep parotid and upper neck. Flexible laryngoscopy revealed a submucosal mass at the level of the oropharynx extending inferiorly into the hypopharynx obstructing the left half of the pharynx. The visualized larynx appeared normal and the true vocal folds were mobile bilaterally. There was no appreciable eyelid ptosis or miosis.
Magnetic resonance imaging demonstrated a 4.6 Â 3.1 Â 7.3 cm heterogeneous mass in the left parapharyngeal space that was T1 hyperintense and T2 hypointense (Figure 3) . The mass displaced the internal carotid artery anteromedially and the external carotid artery laterally. There was effacement of the oropharynx with associated nasopharyngeal and oropharyngeal airway narrowing. There was no mucosal involvement or lymphadenopathy. The lesion was discrete from the parotid gland raising concern for a carotid body paraganglioma or vagal nerve schwannoma. Preoperative urinary cathecholamine testing was negative.
Given the patient's age, symptoms, and airway narrowing the patient was taken for surgical resection of the mass via a transcervical approach. Intraoperatively, the mass was surrounded by a dense fibrous capsule that was tightly adherent to the surrounding structures. The vagus nerve was posterior to the mass and hypoglossal nerve was lateral to the mass. Both were separable from the mass. The internal carotid artery crossed anterior to the mass as the mass extended superiorly to the skull base and was dissected off the capsule. The mass had areas of darker pigmentation and frozen section analysis was obtained which revealed a tumor with extensive hemosiderin deposition without malignant features with diagnosis deferred to permanent pathology.
Microscopic examination showed an extensively pigmented melanocytic neoplasm with epithelioid cytology and nests and sheets of tumor cells separated by fibrous strands. No psammoma bodies were seen in this case. Areas of tumor necrosis, widespread nuclear atypia with macronucleoli, and foci of vascular invasion were identified (Figure 4) . The neoplastic cells were S100 positive, though Melan-A staining was negative. A reticulin stain was again performed which outlined the pericellular network pattern. The Ki-67 proliferative index was 23%. These histologic features, in corroboration with the immunoprofile, supported a diagnosis of malignant melanotic schwannoma. The patient's tumor was sent to Foundation One 8 (Cambridge, Massachusetts) for molecular testing which revealed an alteration in the ATM R250 gene which encodes a kinase that plays a key role in the DNA damage response. 9 Postoperatively, the patient's palate asymmetrically raised to the right. However, on laryngoscopy, his true vocal folds were mobile bilaterally. Staging workup including CT chest, abdomen, and pelvis and nuclear medicine bone scan was negative for metastatic disease. Given the elevated Ki-67, tumor necrosis, and vascular invasion, the patient received adjuvant radiation of 60 gray. Given the association of melanotic schwannomas with Carney complex he was referred for genetic testing.
Discussion
Melanotic schwannoma is a rare tumor of neural crest origin that shares a common IHC profile with malignant melanoma. The most common location of a pigmented melanotic schwannoma is a spinal nerve root, and it has been very rarely described in the head and neck. [3] [4] [5] [6] Diagnosis of this lesion is challenging both radiologically and pathologically. Preoperatively, it is frequently mistaken for a carotid body tumor given its radiographic appearance, proximity to the carotid bulb, and vascularity; intraoperatively, its frozen section pathologic appearance raises concern for malignant melanoma. The immunohistochemical analysis and reticulin staining, as well as the relationship of the mass to the cervical sympathetic sheath is crucial in the diagnosis.
The patient in case one presented with a progressively enlarging neck mass raising concern for malignancy. Indeed, the initial intraoperative frozen section was concerning for malignant melanoma. Immunohistochemistry was positive for the melanoma markers HMB-45, Melan-A, and S100. However, malignant melanoma typically would present with increased mitotic activity and absence of psammoma bodies. Our specimen showed scattered psammomatous calcifications and no mitotic figures, thus casting doubt on the diagnosis of malignant melanoma. It is important to note that the absence of psammoma bodies does not preclude a diagnosis of melanotic schwannoma as only 10% to 40% of melanotic schwannomas contain psammoma bodies. 2, 10 Furthermore, the clinicopathologic features of tumors with and without psammoma bodies are similar. 2 In contrast, the patient in case 2 presented with a parapharyngeal space mass. Immunohistochemical analysis of the tumor in case 2 was also positive for melanoma markers, specifically S100. Although the S100 immunoperoxidase stain is a sensitive marker for melanomas, it is not a melanoma-specific stain as it is also positive in other neoplasms of neural origin, cartilaginous tumors, and salivary gland neoplasms.
11 Unlike the first case, tumor necrosis, mitotic activity, widespread nuclear atypia, and vascular invasion were identified on microscopic examination. This, in addition to the elevated Ki-67 proliferative index, led to a malignant diagnosis and recommendation of adjuvant radiation.
Diagnosis of melanotic schwannoma is challenging both radiologically and pathologically. Clear communication between the surgeon, radiologist, and pathologist; understanding of the anatomical relationship of the mass; and close attention to histologic findings are crucial to making the correct diagnosis. Furthermore, while pigmented melanotic schwannoma is typically sporadic, it can be identified as part of an autosomal dominant syndrome called Carney complex, especially when tumor is identified at an earlier age. 12 Carney complex includes myxomas of the heart, skin or breast, spotty pigmentation, and Cushing syndrome and can be associated with pigmented melanotic schwannomas in up to 50% of cases.12 It is important to note that of the 31 patients in Carney's original series of psammomatous melanotic schwannomas, 14 (45%) showed no other evidence of Carney complex. 13 Although immunohistochemical stains are useful in narrowing the differential diagnosis of a pigmented melanocytic lesions, both melanotic schwannoma and melanoma may express S100 or other melanocytic markers. The reticulin stain is extremely useful tool in the differentiation between melanotic schwannoma and melanoma. In pigmented melanotic schwannomas, there is an abundant reticulin meshwork that envelops each individual tumor cell, as opposed to melanoma where nests or larger groups of tumor cells are surrounded by reticulin fibers.1 The reticulin stain was used in both cases to aid in the diagnosis of melanotic schwannoma.
Although melanotic schwannoma has previously been described as clinically benign, recent studies have advocated for reconsideration of the tumor as a malignancy. In the largest series evaluating the clinicopathologic, immunohistochemical, and genetic profiling of melanotic schwannoma, Torres-Mora et al 2 found rates of distant metastases of 42% involving lung, liver, brain, bone, and leptomeninges. The local recurrence rate was 35% with a disease-specific mortality of 27%. Ultimately, the authors concluded that melanotic schwannoma should be identified as a separate, malignant neoplastic entity. In a retrospective review of 5 spinal melanotic schwannomas, VallatDecouvelaere et al7 reported metastases in 4 of 5 patients with 3 having died from metastases. Their review of 57 cases reported in the literature showed that 15% of the cases had recurrences and 26.3% had metastases. They also observed a delay in recurrence or metastases of 5 years or more after initial diagnosis, and a poor overall long-term prognosis. Although the malignant potential of melanotic schwannoma is now better recognized, multiple studies have failed to identify definitive morphological features that predict malignant behavior, 1, 3, 7 perhaps with the exception of elevated mitotic activity.2 Therefore, predicting and characterizing the biologic behavior of melanotic schwannoma is difficult.
Given the rarity of this diagnosis, there are no standard guidelines for diagnosis and treatment. Complete surgical excision is typically undertaken, but the efficacy of adjuvant therapy such as chemotherapy, radiotherapy, or immunotherapy is not well defined. 3, 4, 7 When complete tumor resection is not possible secondary to local infiltration, adjuvant radiotherapy to prevent local recurrences and metastases is suggested. 7, 14 As reported by multiple studies in the past, the natural history of melanotic schwannoma is unpredictable, and its biologic behavior is uncertain. Many researchers have suggested that this tumor should be considered a malignant neoplasm and be reclassified in its own category. As such, careful diagnostic examinations should be considered and the patients must be followed closely for an extended period of time given the propensity for long-term recurrence and metastasis.
Pigmented melanotic schwannoma is an uncommon diagnosis, and even more rare in the head and neck region. A pigmented neck mass arising from the nerve sheath should be examined with IHC and a reticulin stain to rule out a melanotic schwannoma. Complete surgical resection of the tumor is the treatment of choice, but not enucleation as is common for nonpigmented schwannomas. Despite a lack of evidence to support the role of adjuvant therapy, it should be considered given the increasing evidence of the aggressiveness of melanotic schwannoma, particularly in lesions with high mitotic activity. Long-term follow-up for melanotic schwannoma is required.
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